HIV is the primary exclusion criterion in a PrePex male circumcision device introductory study in Mozambique

Similar documents
Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia

Tool C Client Record Review

INTRODUCTION. 204 MCHIP End-of-Project Report

Building the capacity to Deliver Early Infant Male Circumcision services in Rwanda: Lessons learnt

A Resource for Demand Creation and Promotion of Voluntary Medical Male Circumcision (VMMC) for HIV Prevention

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa

UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA

ACHAP LESSONS LEARNED IN BOTSWANA KEY INITIATIVES

Community-Based TasP Trials: Updates and Projected Contributions. Reaching the target: Lessons from HPTN 071 (PopART) Sarah Fidler

Development of Tools for Monitoring & Reporting VMMC Program Indicators

Beyond the Horizon: Recruiting for VMMC services at Bwaila ANC and STI clinics. Geoffrey Menego, Project IQ Malawi 6 th February 2019

Male Circumcision in Zambia: National Operational Plan for Scale-up

Ever enrolled Currently enrolled Ever on ART Sub- County Adults Peds Total Adults Peds Total Adults Peds Total Adults Peds Total

Voluntary Medical Male Circumcision (VMMC) Training Kit. Facilitators Guide

Policies for VMMC in 14 priority countries of east and southern Africa

Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana

UNITED REPUBLIC OF TANZANIA Ministry of Health and Social Welfare NATIONAL AIDS CONTROL PROGRAM

USING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa

Applying Continuous Quality Improvement (CQI) in Voluntary Medical Male Circumcision (VMMC) in South Africa

INNOVATIONS IN VMMC SERVICE DELIVERY IN KENYA

Program Overview. Supported by PEPFAR/HRSA Grant Number U91HA06801

CASE STUDY Improving the quality of VMMC services at Mangochi, Mzimba North, and Nkhotakota District Hospitals in Malawi

Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe

Using Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire

90% 90% 90% 30% 10% 5% 70% 90% 95% WHY HIV SELF-TESTING? PLHIV diagnosed PLHIV undiagnosed

Ministry of Health. Swaziland HIV Incidence Measurement Survey (SHIMS)

Introducing Early Infant Male Circumcision (EIMC): DMPPT 2.0 Modeling

Mozambique Test and Start Cost Analysis

BD-PEPFAR Labs for Life Partnership

Chapter 7: Management of Adverse Events and Side Effects

Tim Farley, Ph.D. Nyon, Switzerland Consultant to WHO/HIV Department 26 September 2012

Adverse Event Action Guide. For Voluntary Medical Male Circumcision (VMMC) by Surgery or Device 2 nd Edition, 2016

Surveillance of Recent HIV Infections: Using a Pointof-Care Recency Test to Rapidly Detect and Respond to Recent Infections

Starting with the end in mind: Experience of transitioning to sustainable services (KZN)

Using Data from Electronic HIV Case Management Systems to Improve HIV Services in Central Asia

Progress in male circumcision scale-up: country implementation update. December 2009

VOLUNTARY MEDICAL MALE CIRCUMCISION KITS THE JOURNEY SO FAR AND THE PATH AHEAD

Scaling up Voluntary Medical Male Circumcision (VMMC) in Southern and Eastern Africa: Successes Achieved and Challenges Overcome

Adverse Event Action Guide For Voluntary Medical Male Circumcision (VMMC) by Surgery or Device 2nd Edition, Updated November 2018

CLINICAL SCIENCE. J Acquir Immune Defic Syndr Volume 61, Number 1, September 1,

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

representing 45% and 35% of VMMC volumes clients in Zambia and Zimbabwe, respectively. An assumed 93% of adults were medically eligible.

HIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa. January December 2012

EXPANDING ACCESS TO HIV SERVICES, EMPOWERING HEALTH WORKERS, AND STRENGTHENING HEALTH SYSTEMS IN KENYA

1. POSITION TITLE : Technical Advisor, TB and HIV. 2. PERIOD OF PERFORMANCE : Two (2) years, with the possibility of

Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2

A Data Use Guide ESTIMATING THE UNIT COSTS OF HIV PREVENTION OF MOTHER-TO-CHILD TRANSMISSION SERVICES IN GHANA. May 2013

Voluntary Medical Male Circumcision Summary of Devices Costing and Modeling Studies

Tool B Facilities, Supplies & Equipment

HP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018

NRHS ANNUAL REPORT-2014

Voluntary Medical Male Circumcision in Military Populations: September 2012 Update

ZAMBIA DEX QUARTERLY REPORTS

DELAYS IN INITIATION OF ANTIRETROVIRAL THERAPY AMONG HIV-INFECTED CHILDREN IN RURAL ZAMBIA 9 th Interest Comference Francis H.

Information for Patients. Phimosis. English

Financing ART in low- and middleincome. Karl L. Dehne UNAIDS

Ministry of Health. National Male Circumcision Strategy and Implementation Plan

Implementation Progress of Appointment Spacing Model of Differentiated HIV service Delivery in Ethiopia

Commissioning Policy Individual Funding Request

HIV Prevention. Recent Advances and Implications for the Caribbean

Circumcision Excerpted from Gentle Baby Care by Elizabeth Pantley

Age of Consent for HIV Testing, Counseling and Treatment in Tanzania

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project

HIV Quality Improvement Initiatives in Mozambique

Primary Coverage. The Benefits of Circumcision Operation Principle Academic Article Circumstapler Advantages Operating Procedure Post Operation Caring

DHHS-Malawi, MCH & HIV Activities

South Africa Country Report FY14

LESOTHO POPULATION-BASED HIV IMPACT ASSESSMENT LePHIA

ESTABLISHING A UNIT COST REPOSITORY FOR HIV INTERVENTIONS IN UGANDA. International AIDS and Economics Network Presented by: Shiba Kanoowe July 2016

Estimating the number of people who inject drugs (PWID) in two urban areas in Mozambique using four different methods, 2014

Dedicated postpartum IUD inserter. Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016

Challenges and Opportunities for Responding to HIV/AIDS in LDCs. Mazuwa Banda Department of HIV/AIDS World Health Organization

Safe Circumcision: New Toolkit for Demand Creation with 1-day training programme

Innovative Ways to Fund Harm Reduction Services New Mexico

DREAMS: Addressing the Elevated Risk for HIV Infection among Young Women

Differentiated Service Delivery: Taking Innovative Delivery Models to Scale

Time to Complete Wound Healing in HIV-Positive and HIV-Negative Men following Medical Male Circumcision in Kisumu, Kenya: A Prospective Cohort Study

Report on MCSP Support for the Polio Switch in April 2016

Death of a Disease in the 21 st Century:

Theresa NeSmith Centers for Disease Control and Prevention Center for Global Health Division of Global HIV/AIDS International Laboratory Branch

Table of Contents. NASTAD s Technical Assistance to the HIV & AIDS District Coordination

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment

Seizing the Opportunity: Working with Adolescent Boys for an HIV-Free Generation

Torin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015

Investing for Impact

See What s New and Bold at PSI. Annual Report

VOLUNTARY MALE MEDICAL CIRCUMCISION CHANGE PACKAGE

Preventing Cervical Cancer Through Effective Data Use: Practical Tools

Webinar What s New in Scaling Up CQI for VMMC

PRECOURSE QUESTIONNAIRE ANSWER KEY

PURSUING STRATEGIC PARTNERSHIPS TO PUSH INNOVATION

Progress in male circumcision scale-up: country implementation and research update. June 2010

TECHNICAL ASSISTANCE TO EXPAND HIV PREVENTION, CARE, AND TREATMENT IN NAMPULA, MOZAMBIQUE

HPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission

PEPFAR S BEST PRACTICES FOR VOLUNTARY MEDICAL MALE CIRCUMCISION SITE OPERATIONS

From HIV Rapid Scale up to a Sustainable HIV Program: Strengthening Health Care Delivery Systems and Human Resources for Health in Ethiopia

increased efficiency. 27, 20

Partnership Frameworks: a five-year path

Better Partner Health

Transcription:

HIV is the primary exclusion criterion in a PrePex male circumcision device introductory study in Mozambique SA HIV Clinicians Society Conference 2014 Ferreira, T*; Mahomed, M*; Bossemeyer, D*; Nhambi, L*; Necochea, E*; Muquingue, H*. Cummings, B** *Jhpiego Mozambique **CDC Mozambique

Background Mozambique has a generalized HIV epidemic with a prevalence of 11.5% in the adult population High HIV prevalence is associated with low circumcision rates Voluntary Medical Male Circumcision (VMMC) started as a pilot in November 2009 Since than more than 350,000 clients had been surgically circumcised 2009, INSIDA 2013, MOH. Strategic National Expansion Plan for VMMC, 2013-2017

Mozambique HIV and MC Prevalence

PrePex - Mozambique Study Progress scaling up the intervention in Mozambique has been slower than expected and MOH aims to circumcise 2 million males by 2017 Recent technological advances, such as circumcision devices, provide viable options for achieving national targets PrePex is a non-surgical circumcision device that could potentially reduce procedure time and increase acceptability for VMMC In 2013, an introductory study of the PrePex device was conducted in Maputo, to assess the acceptability of the PrePex device among providers and clients

PrePex device: the parts Source: PrePex website

Nurses during PrePex training Methods Adult clients presenting for VMMC at the study site in Maputo were offered a choice of conventional surgery (forceps-guided technique) or PrePex Those who preferred PrePex were screened for inclusion criteria. Exclusion criteria were recorded

Eligibility: Exclusion Criteria Clinical medical conditions Bleeding issues or abnormal coagulation Anatomical abnormalities Active genital infections Narrow foreskin or foreskin with limited flexibility Warts in the foreskin Torn or tight foreskin frenulum (adhesion below the glans) Phimosis Paraphimosis Hypospadias Epispadias Positive HIV test result Social Communication requirements Able to understand the study procedures and requirements Lives within 25 kilometers of the health center Has a working mobile phone Able to communicate in Portuguese Able and willing to provide informed consent in writing

Referred to HIV care and treatment services Recruitment Flow

Findings Ineligibility reasons for circumcision with PrePex device % Reason n HIV+ 65 62.5% Phimosis 11 10.6% No cell phone 8 7.7% Poor communication in Portuguese 7 6.7% Ineligible age* 6 5.8% Lack of understanding of the study 2 1.9% Genital infection 2 1.9% Sexual dysfunction 1 1% Narrow foreskin 1 1% Mental disorder 1 1% Total 104 100% * Clients excluded after re-verification of age.

Discussion Of the 608 clients assessed, 104 were determined to be ineligible, representing 17% of those who opted for PrePex HIV sero-positivity was the main cause for ineligibility (62.5% of the ineligible) 10.7% of HIV prevalence during the study was much higher than that found in surgical circumcision clients at José Macamo HC (3.4%) - This could be related to the fact that PrePex clients were older, aged 18 to 49 years, than the average client for surgical circumcision.

Conclusions An integrated program offering both device and surgical VMMC is the best service delivery option to ensure that HIV positive clients receive VMMC and to expand choices for prospective VMMC clients A positive HIV test should not exclude for PrePex: in fact, once bridging (safety) studies of PrePex in HIV positive men are complete presumably testing positive for HIV will not be an exclusion criteria to PrePex.

Acknowledgments Bill and Melinda Gates Foundation PSI Mozambique Ministry of Health CDC Mozambique: This research has been partially supported by the President s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Grant #1U2GPS001542. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC. Presenter s email: thais.ferreira@jhpiego.org